These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
543 related articles for article (PubMed ID: 10790590)
1. [Functional compartmentation of the endocrine action of cardiac natriuretic peptides]. Haloui M; Arnal JF; Pham I; Gonzalez W; Lyoussi B; Michel JB Ann Endocrinol (Paris); 2000 Feb; 61(1):32-40. PubMed ID: 10790590 [TBL] [Abstract][Full Text] [Related]
2. Potentiation of urinary atrial natriuretic peptide interferes with macula densa function. Haloui M; Messika-Zeitoun D; Louedec L; Philippe M; Michel JB Cardiovasc Res; 2001 Aug; 51(3):542-52. PubMed ID: 11476744 [TBL] [Abstract][Full Text] [Related]
3. Antihypertrophic actions of the natriuretic peptides in adult rat cardiomyocytes: importance of cyclic GMP. Rosenkranz AC; Woods RL; Dusting GJ; Ritchie RH Cardiovasc Res; 2003 Feb; 57(2):515-22. PubMed ID: 12566124 [TBL] [Abstract][Full Text] [Related]
4. Neutral endopeptidase inhibition potentiates the effects of natriuretic peptides in renin transgenic rats. Wegner M; Ganten D; Stasch JP Hypertens Res; 1996 Dec; 19(4):229-38. PubMed ID: 8986453 [TBL] [Abstract][Full Text] [Related]
5. Clearance receptors and endopeptidase: equal role in natriuretic peptide metabolism in heart failure. Rademaker MT; Charles CJ; Kosoglou T; Protter AA; Espiner EA; Nicholls MG; Richards AM Am J Physiol; 1997 Nov; 273(5):H2372-9. PubMed ID: 9374774 [TBL] [Abstract][Full Text] [Related]
6. George E. Brown memorial lecture. Role of atrial peptides in body fluid homeostasis. Ballermann BJ; Brenner BM Circ Res; 1986 May; 58(5):619-30. PubMed ID: 3011307 [TBL] [Abstract][Full Text] [Related]
7. Equimolar doses of atrial and brain natriuretic peptides and urodilatin have differential renal actions in overt experimental heart failure. Chen HH; Cataliotti A; Schirger JA; Martin FL; Burnett JC Am J Physiol Regul Integr Comp Physiol; 2005 May; 288(5):R1093-7. PubMed ID: 15627648 [TBL] [Abstract][Full Text] [Related]
8. Natriuretic peptides in the pathophysiology of congestive heart failure. Chen HH; Burnett JC Curr Cardiol Rep; 2000 May; 2(3):198-205. PubMed ID: 10980893 [TBL] [Abstract][Full Text] [Related]
9. Cardiorenal and neurohumoral effects of endogenous atrial natriuretic peptide in dogs with severe congestive heart failure using a specific antagonist for guanylate cyclase-coupled receptors. Wada A; Tsutamoto T; Matsuda Y; Kinoshita M Circulation; 1994 May; 89(5):2232-40. PubMed ID: 7910118 [TBL] [Abstract][Full Text] [Related]
10. Differing biological effects of equimolar atrial and brain natriuretic peptide infusions in normal man. Hunt PJ; Espiner EA; Nicholls MG; Richards AM; Yandle TG J Clin Endocrinol Metab; 1996 Nov; 81(11):3871-6. PubMed ID: 8923831 [TBL] [Abstract][Full Text] [Related]
11. Effects of natriuretic peptides on ventricular myocyte contraction and role of cyclic GMP signaling. Zhang Q; Moalem J; Tse J; Scholz PM; Weiss HR Eur J Pharmacol; 2005 Mar; 510(3):209-15. PubMed ID: 15763244 [TBL] [Abstract][Full Text] [Related]
12. Role of endogenous atrial natriuretic peptide in DOCA-salt hypertensive rats. Effects of a novel nonpeptide antagonist for atrial natriuretic peptide receptor. Hirata Y; Matsuoka H; Suzuki E; Hayakawa H; Sugimoto T; Matsuda Y; Morishita Y; Kangawa K; Minamino N; Matsuo H Circulation; 1993 Feb; 87(2):554-61. PubMed ID: 8381060 [TBL] [Abstract][Full Text] [Related]
13. Natriuretic peptide analogues with distinct vasodilatory or renal activity: integrated effects in health and experimental heart failure. Rademaker MT; Scott NJA; Koh CY; Kini RM; Richards AM Cardiovasc Res; 2021 Jan; 117(2):508-519. PubMed ID: 32167565 [TBL] [Abstract][Full Text] [Related]
14. Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling. Madhani M; Scotland RS; MacAllister RJ; Hobbs AJ Br J Pharmacol; 2003 Aug; 139(7):1289-96. PubMed ID: 12890708 [TBL] [Abstract][Full Text] [Related]
15. [Effect of digoxin on atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and cyclic 3', 5'-guanosine monophosphate (cGMP) in patients with chronic congestive heart failure]. Kobusiak-Prokopowicz M; Swidnicka-Szuszkowska B; Mysiak A Pol Arch Med Wewn; 2001 Jun; 105(6):475-82. PubMed ID: 11865578 [TBL] [Abstract][Full Text] [Related]
16. Renal, endocrine, and hemodynamic interactions of atrial and brain natriuretic peptides in normal men. Florkowski CM; Richards AM; Espiner EA; Yandle TG; Frampton C Am J Physiol; 1994 Apr; 266(4 Pt 2):R1244-50. PubMed ID: 8184968 [TBL] [Abstract][Full Text] [Related]
17. Effects of exogenous and endogenous natriuretic peptides on forearm vascular function in chronic heart failure. Schmitt M; Gunaruwan P; Payne N; Taylor J; Lee L; Broadley AJ; Nightingale AK; Cockcroft JR; Struthers AD; Tyberg JV; Frenneaux MP Arterioscler Thromb Vasc Biol; 2004 May; 24(5):911-7. PubMed ID: 15001459 [TBL] [Abstract][Full Text] [Related]